Advances in experimental medicine and biology, Journal Year: 2025, Volume and Issue: unknown, P. 211 - 242
Published: Jan. 1, 2025
Language: Английский
Advances in experimental medicine and biology, Journal Year: 2025, Volume and Issue: unknown, P. 211 - 242
Published: Jan. 1, 2025
Language: Английский
Biomedicines, Journal Year: 2025, Volume and Issue: 13(2), P. 340 - 340
Published: Feb. 3, 2025
Background/Objectives: Dementia associated with diabetes mellitus (DM) has been well documented in the literature, but studies utilizing early screening tools to target populations mild cognitive dysfunction remain limited. This study aimed investigate decline by studying relationships between “Ascertain 8” (AD8) questionnaire scores and glycemic control, lipid profiles, estimated glomerular filtration rate (eGFR), complications of diabetes. Methods: case–control, cross-sectional, observational was conducted at a medical center an affiliated regional hospital southern Taiwan from 30 June 2021 2023. Patients diagnosed type 2 aged ≥40 years were recruited. Their past history, biochemical data, AD8 score collected same time. Results: The patients glycated hemoglobin (HbA1c) levels ≥7% had higher risk impairment than those HbA1c <7% (p < 0.001). participants whose eGFR <60 mL/min/1.73 m2 mean compared ≥60 = 0.008). history peripheral artery disease diabetic neuropathy also 0.001 p 0.017, respectively). Conclusions: By employing as sensitive tool, our suggests that is significantly poorer lower rate, disease, neuropathy. Early detection these factors may facilitate timely interventions tailored treatment strategies treat or prevent dysfunction.
Language: Английский
Citations
0Neurobiology of Disease, Journal Year: 2025, Volume and Issue: unknown, P. 106877 - 106877
Published: March 1, 2025
Language: Английский
Citations
0European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 177526 - 177526
Published: March 1, 2025
Language: Английский
Citations
0Frontiers in Psychiatry, Journal Year: 2025, Volume and Issue: 16
Published: March 21, 2025
Background Given that atrial fibrillation (AF) s associated with a high risk of psychiatric disorders, understanding the potential benefits catheter ablation is clinically significant. This study was conducted to examine whether can prevent disorders in patients AF. Methods A retrospective cohort over two years using data from TriNetX electronic health record network. The included adults diagnosed AF and treated either antiarrhythmic or rate-control medications. Participants were divided into groups: those who underwent control group without ablation. primary outcome measured composite anxiety, depression, insomnia occurrence within one three post-treatment. Secondary outcomes individual suicidal ideation attempts, dementia, cerebral infarction, atopic dermatitis (as negative control). Results We 21,019 each matched group. demonstrated lower combined (hazard ratio(HR):0.873, 95% confidence interval (CI) 0.784–0.973, p<0.01), secondary including anxiety (HR:0.822, CI:0.700–0.964; p=0.016), depression (HR:0.614, CI:0.508–0.743; p<0.001), attempts (HR:0.392, CI:0.165–0.934; p=0.028), dementia (HR:0.569, CI:0.422–0.767; infarction (HR:0.704, CI:0.622–0.797; p<0.001) compared non-ablation Conclusions In fibrillation, reduced developing insomnia, attempt, comparison did not undergo Clinicians should consider incorporating factors their comprehensive patient assessment when evaluating candidates for
Language: Английский
Citations
0Advances in experimental medicine and biology, Journal Year: 2025, Volume and Issue: unknown, P. 211 - 242
Published: Jan. 1, 2025
Language: Английский
Citations
0